Literature DB >> 8650473

Pathogenesis of chronic Chagas' myocarditis.

M A Rossi1.   

Abstract

The pathogenesis of chronic Chagas' myocarditis is still not completely understood. Several theories have been advanced: 1) direct tissue destruction by Trypanosoma cruzi; 2) neurogenic theory; 3) anti-heart immune reactions; and 4) microvascular disease. We present herein a dynamic alternative hypothesis. We believe that the development of myocarditis is related to progressive and additive focal cellular necrosis, and associated reactive and reparative myocardial fibrosis and surrounding myocyte hypertrophy. These processes may be initiated and perpetuated by anti immune factors and alterations in the myocardial microcirculation. The destruction of the ganglion cells of the heart may be involved in the patho-clinical evolution of chronic Chagas' cardiopathy. This could imply future therapeutic strategies in the management of chronic Chagas' patients to enhance medical treatment and, hopefully, improve prognosis.

Entities:  

Mesh:

Year:  1995        PMID: 8650473     DOI: 10.1590/s1516-31801995000200004

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  7 in total

1.  Fas ligand-dependent inflammatory regulation in acute myocarditis induced by Trypanosoma cruzi infection.

Authors:  Gabriel Melo de Oliveira; Rafaela Lopes Diniz; Wanderson Batista; Marcelo Meuser Batista; Cristiane Bani Correa; Tânia Cremonini de Araújo-Jorge; Andréa Henriques-Pons
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

2.  Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses.

Authors:  Leonardo Freire-de-Lima; Frederico Alisson-Silva; Sebastião T Carvalho; Christina M Takiya; Maurício M Rodrigues; George A DosReis; Lucia Mendonça-Previato; José O Previato; Adriane R Todeschini
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

3.  Administration of artinm lectin reduces the severity of the acute phase infection with Trypanosoma cruzi.

Authors:  Camila Botelho Miguel; Thiago Aparecido da Silva; Wellington Francisco Rodrigues; Patrícia Kellen Martins Oliveira-Brito; Maria Cristina Roque-Barreira; Javier Emílio Lazo-Chica
Journal:  FASEB Bioadv       Date:  2021-01-25

4.  Inflammatory responses and intestinal injury development during acute Trypanosoma cruzi infection are associated with the parasite load.

Authors:  Bruna Perez Vazquez; Thaís Perez Vazquez; Camila Botelho Miguel; Wellington Francisco Rodrigues; Maria Tays Mendes; Carlo José Freire de Oliveira; Javier Emílio Lazo Chica
Journal:  Parasit Vectors       Date:  2015-04-03       Impact factor: 3.876

5.  Renovascular hypertension increases serum TNF and CX3CL1 in experimental Trypanosoma cruzi infection.

Authors:  M C Silva; M A Azevedo; V P Figueiredo; M R Moura Junior; D Coelho Junior; P M Martinelli; R P Machado; A C Alzamora; A Talvani
Journal:  Braz J Med Biol Res       Date:  2018-03-26       Impact factor: 2.590

6.  Betulinic Acid Derivative BA5, Attenuates Inflammation and Fibrosis in Experimental Chronic Chagas Disease Cardiomyopathy by Inducing IL-10 and M2 Polarization.

Authors:  Cássio Santana Meira; Emanuelle De Souza Santos; Renan Fernandes do Espírito Santo; Juliana Fraga Vasconcelos; Iasmim Diniz Orge; Carolina Kymie Vasques Nonaka; Breno Cardim Barreto; Alex Cleber Improta Caria; Daniela Nascimento Silva; José Maria Barbosa-Filho; Simone Garcia Macambira; Diogo Rodrigo Magalhães Moreira; Milena Botelho Pereira Soares
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

7.  CD43 sialoglycoprotein modulates cardiac inflammation and murine susceptibility to Trypanosoma cruzi infection.

Authors:  Frederico Alisson-Silva; Natália Rodrigues Mantuano; Ana Luiza Lopes; Andréia Vasconcelos-Dos-Santos; André Macedo Vale; Miriam Maria Costa; Judy L Cannon; Ana Carolina Oliveira; Adriane R Todeschini
Journal:  Sci Rep       Date:  2019-06-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.